Following CVL collection, samples were centrifuged at 10,000g for 5 min after which supernatants and cell pellets were stored at ?80C until used. none to 100% inhibition depending on the viral strains used. CVL from HIV(?) controls showed comparable anti-HIV activity. Analysis of CH077.c (clone of an R5-tropic, mucosally-transmitted founder computer virus) viral inhibition by CVL was comparable to laboratory strains. Measurement of CVL for antimicrobials HBD2, trappin-2/elafin, SLPI and MIP3 indicated that each was present in CVL from HIV(+) and HIV(?) women. HBD2 and MIP3 correlated with anti-HIV activity as did anti-gp160 HIV IgG antibodies in CVL from HIV(+) women. Conclusions/Significance These findings show that CVL from healthy HIV(+) and HIV(?) women contain innate and adaptive defense mechanisms that inhibit HIV contamination. Our data suggest that innate endogenous antimicrobials and HIV-specific IgG in the FRT can take action in concert to contribute toward the anti-HIV activity of the CVL and may play a role in inhibition of HIV transmission to women. Introduction Heterosexual transmission of HIV is the predominant driver of the growing HIV pandemic [1], [2]. Yet, while considerable attention has been directed to developing topical exogenous microbicides that reduce Rbin-1 transmission of HIV-1, relatively little is known about endogenous microbicides produced within the female reproductive tract (FRT). That endogenous microbicides in the female reproductive tract secretions might limit or prevent HIV transmission is usually Rbin-1 suggested by the relatively low risk of HIV transmission per heterosexual coitus, from 1122 to 11000 [3], [4]. We as well as others have shown that cells of the FRT produce and secrete a spectrum of cytokines, chemokines, and antimicrobials [5]C[8]. Several specifically inhibit HIV contamination of target cells [9], [10]. Antimicrobials secreted by FRT cells include well-characterized anti-HIV molecules, alpha/beta defensins, lactoferrin, and secretory leukocyte protease inhibitor (SLPI), as well as factors such as trappin-2/elafin and MIP3, which have recently been shown to have anti-HIV activity [9]C[13]. Some of these factors such as human beta defensins 2 (HBD2) take action directly to inhibit computer virus [10], while others including SDF1, RANTES, MIP1, and MIP1 bind to co-receptors to prevent viral access into target cells [14]. Recent studies have linked the presence of cationic polypeptides in CVL to anti-HSV and anti-HIV activity [15], [16]. Venkataraman showed that when all cationic polypeptides were depleted from your CVL, antimicrobial activity was lost [16]. The isolation of HIV-1 in the FRT was first reported in 1986 [17]. Since then, numerous studies have reported the presence of cell-free HIV-1 RNA, cell-associated HIV-1 RNA, proviral DNA, and culturable computer virus from your cervix and vagina of pregnant and non-pregnant infected women [18]C[20]. While it is usually obvious that HIV-1 is usually shed into the FRT, a detailed understanding of this phenomenon and factors that affect the Rbin-1 amount and infectivity of computer virus in the FRT has not yet been elucidated. Reichelderfer reported that HIV-1 RNA levels in endocervical secretions were highest in the week preceding menses [21]. Other studies have shown no effect of the menstrual cycle on the amount or infectivity of HIV-1 in the FRT [22]. In a recent study, the number of HIV-1 infected cells in endocervical secretions was reported to increase at midcycle just after the periovulatory phase [23]. In other studies, Cummins and colleagues showed that certain innate immune factors in vaginal lavages were more closely associated with HIV-1 shedding in the genital mucosa than plasma viral weight [24]. Whether computer virus is usually shed into the vagina from your upper FRT remains to be decided. Whereas HIV-1 shedding in CVL secretions is usually readily detectable, it remains unclear what percentage of Eng the shed computer virus is actually infectious [24], [25]. In this study, we assessed the levels of multiple candidate endogenous microbicides in cervicovaginal lavage (CVL) specimens from HIV(+) and HIV(?) women, and characterized whether these microbicides correlate with protection from HIV contamination. Of the four microbicides analyzed, we found that the levels of two endogenous microbicides, HBD2 and MIP3 correlated with activity against HIV. Analysis of CVL for HIV-specific IgG of healthy HIV(+) women further indicated a positive correlation with anti-HIV activity. These Rbin-1 data show that CVL from HIV(+) and HIV(?) women contain endogenously produced antimicrobials and IgG (HIV+ samples) that correlate with protection against HIV contamination. Further, these findings suggest that, as a consequence of antimicrobial activity in the lower FRT, an environment exists for viral inactivation, which.